PG Stock Cash Flow Statements

Procter & Gamble Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Procter & Gamble Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30

cash, cash equivalents and restricted cash, beginning of year
operating activities
net earnings	3,626,000,000	3,793,000,000	4,659,000,000	3,987,000,000	3,144,000,000	3,781,000,000	3,493,000,000	4,556,000,000	3,392,000,000	3,424,000,000	3,959,000,000	3,963,000,000	3,058,000,000	3,367,000,000	4,242,000,000	4,126,000,000	2,908,000,000	3,249,000,000	3,887,000,000	4,308,000,000	2,786,000,000	2,957,000,000	3,743,000,000	3,617,000,000	-5,237,000,000	2,776,000,000	3,216,000,000	3,211,000,000	1,890,000,000	2,540,000,000	2,561,000,000	2,870,000,000	2,202,000,000	2,556,000,000	7,896,000,000	2,757,000,000	1,958,000,000
depreciation and amortization	723,000,000	690,000,000	706,000,000	728,000,000	761,000,000	712,000,000	721,000,000	702,000,000	706,000,000	692,000,000	653,000,000	663,000,000	722,000,000	690,000,000	684,000,000	711,000,000	710,000,000	683,000,000	671,000,000	671,000,000	814,000,000	799,000,000	677,000,000	723,000,000	820,000,000	711,000,000	650,000,000	643,000,000	750,000,000	716,000,000	676,000,000	692,000,000	720,000,000	665,000,000	707,000,000	728,000,000	839,000,000
share-based compensation expense	112,000,000	123,000,000	136,000,000	105,000,000	129,000,000	158,000,000	150,000,000	125,000,000	139,000,000	156,000,000	145,000,000	105,000,000	130,000,000	130,000,000	152,000,000	116,000,000	142,000,000	144,000,000	165,000,000	89,000,000	233,000,000	123,000,000	92,000,000	110,000,000	216,000,000	118,000,000	79,000,000	102,000,000	146,000,000	92,000,000	73,000,000	84,000,000	154,000,000	93,000,000	60,000,000	44,000,000	119,000,000
deferred income taxes	-34,000,000	-38,000,000	37,000,000	184,000,000	-38,000,000	-52,000,000	-256,000,000	102,000,000	-93,000,000	38,000,000	-268,000,000	-130,000,000	-143,000,000	-158,000,000	-158,000,000	57,000,000	-91,000,000	-312,000,000	-48,000,000	193,000,000	-8,000,000	-39,000,000	37,000,000	-586,000,000	-387,000,000	-61,000,000	3,000,000	34,000,000	-18,000,000	182,000,000	-2,434,000,000	426,000,000	-219,000,000	66,000,000	-271,000,000	-177,000,000	-387,000,000
loss/(gain) on sale of assets	-27,000,000	-5,000,000	-7,000,000	794,000,000													-1,000,000
indefinite-lived intangible asset impairment charge					0	0
change in accounts receivable	124,000,000	183,000,000	-128,000,000	-134,000,000
change in inventories	85,000,000	-239,000,000	18,000,000	-188,000,000
change in accounts payable
other	-1,871,000,000	83,000,000	103,000,000	32,000,000	479,000,000	144,000,000	138,000,000	208,000,000	201,000,000	139,000,000	162,000,000	62,000,000	142,000,000	34,000,000	9,000,000	44,000,000	36,000,000	-11,000,000	70,000,000	40,000,000	57,000,000	31,000,000	19,000,000	1,000,000	88,000,000	61,000,000	106,000,000	58,000,000	230,000,000	53,000,000	52,000,000	96,000,000	114,000,000	-19,000,000	41,000,000	26,000,000	-3,000,000
total operating activities	4,985,000,000	3,705,000,000	4,825,000,000	4,302,000,000	5,754,000,000	4,088,000,000	5,100,000,000	4,904,000,000	5,341,000,000	3,863,000,000	3,574,000,000	4,070,000,000	3,713,000,000	3,246,000,000	5,121,000,000	4,643,000,000	4,121,000,000	4,087,000,000	5,424,000,000	4,739,000,000	4,806,000,000	4,064,000,000	4,364,000,000	4,169,000,000	4,151,000,000	3,517,000,000	4,007,000,000	3,567,000,000	4,199,000,000	3,353,000,000	3,684,000,000	3,631,000,000	3,688,000,000	3,040,000,000	3,000,000,000	3,025,000,000	4,139,000,000
investing activities
capital expenditures	-996,000,000	-859,000,000	-925,000,000	-993,000,000	-783,000,000	-797,000,000	-817,000,000	-925,000,000	-734,000,000	-730,000,000	-708,000,000	-890,000,000	-692,000,000	-747,000,000	-626,000,000	-1,091,000,000	-714,000,000	-656,000,000	-567,000,000	-850,000,000	-658,000,000	-731,000,000	-605,000,000	-1,079,000,000	-814,000,000	-752,000,000	-701,000,000	-1,080,000,000	-907,000,000	-910,000,000	-768,000,000	-1,132,000,000	-1,154,000,000	-801,000,000	-745,000,000	-684,000,000	-1,291,000,000
free cash flows	3,989,000,000	2,846,000,000	3,900,000,000	3,309,000,000	4,971,000,000	3,291,000,000	4,283,000,000	3,979,000,000	4,607,000,000	3,133,000,000	2,866,000,000	3,180,000,000	3,021,000,000	2,499,000,000	4,495,000,000	3,552,000,000	3,407,000,000	3,431,000,000	4,857,000,000	3,889,000,000	4,148,000,000	3,333,000,000	3,759,000,000	3,090,000,000	3,337,000,000	2,765,000,000	3,306,000,000	2,487,000,000	3,292,000,000	2,443,000,000	2,916,000,000	2,499,000,000	2,534,000,000	2,239,000,000	2,255,000,000	2,341,000,000	2,848,000,000
proceeds from asset sales	43,000,000	17,000,000	2,000,000	45,000,000	269,000,000	69,000,000	5,000,000	3,000,000	37,000,000	1,000,000	3,000,000	5,000,000	11,000,000	2,000,000	12,000,000	85,000,000	2,000,000	1,000,000	18,000,000	21,000,000	2,000,000	13,000,000	9,000,000	6,000,000	372,000,000	4,000,000	9,000,000	9,000,000	23,000,000	45,000,000	81,000,000	120,000,000	160,000,000	131,000,000	97,000,000	183,000,000	318,000,000
acquisitions, net of cash acquired	0	-5,000,000	0	-6,000,000	0				-51,000,000	-638,000,000	-74,000,000	-2,000,000	0	-1,032,000,000							0	-4,000,000			-2,000,000	-95,000,000	-3,611,000,000	-237,000,000	-1,000,000	-7,000,000			0	0	-2,000,000	-14,000,000	0
other investing activity	-108,000,000	120,000,000	1,000,000	-154,000,000	-4,000,000	-14,000,000	-189,000,000	-300,000,000	-50,000,000	-13,000,000
total investing activities	-1,063,000,000	-726,000,000	-921,000,000	-1,108,000,000	-518,000,000	-762,000,000	-1,002,000,000	-1,222,000,000	-798,000,000	-1,380,000,000	-490,000,000	-832,000,000	-682,000,000	-1,776,000,000	-960,000,000	-1,006,000,000	-791,000,000	-665,000,000	-549,000,000	-829,000,000	-659,000,000	-725,000,000	-650,000,000	5,079,000,000	647,000,000	573,000,000	-3,845,000,000	-865,000,000	97,000,000	97,000,000	-1,171,000,000	-2,534,000,000	-1,866,000,000	-1,802,000,000	100,000,000	-2,121,000,000	-1,192,000,000
financing activities
dividends to shareholders	-2,553,000,000	-2,433,000,000	-2,441,000,000	-2,445,000,000	-2,449,000,000	-2,285,000,000	-2,288,000,000	-2,290,000,000	-2,289,000,000	-2,224,000,000	-2,231,000,000	-2,255,000,000	-2,262,000,000	-2,155,000,000	-2,171,000,000	-2,182,000,000	-2,197,000,000	-2,011,000,000	-2,025,000,000	-2,030,000,000	-2,028,000,000	-1,906,000,000	-1,923,000,000	-1,932,000,000	-1,937,000,000	-1,858,000,000	-1,850,000,000	-1,853,000,000	-1,861,000,000	-1,813,000,000	-1,813,000,000	-1,823,000,000	-1,826,000,000	-1,773,000,000	-1,786,000,000	-1,851,000,000	-1,847,000,000
additions to short-term debt with original maturities of more than three months	2,115,000,000	0	1,815,000,000	4,090,000,000	567,000,000	163,000,000	619,000,000	2,179,000,000	3,390,000,000	3,331,000,000	7,472,000,000	2,975,000,000	265,000,000
reductions in short-term debt with original maturities of more than three months	-2,731,000,000	-3,210,000,000	0	-571,000,000	-166,000,000	-1,661,000,000	-3,956,000,000	-1,906,000,000	-3,897,000,000	-5,874,000,000	-2,995,000,000	-265,000,000	-3,315,000,000	-6,433,000,000
net additions/(reductions) to other short-term debt	-595,000,000	2,162,000,000	-2,261,000,000	-444,000,000	-1,474,000,000	-1,409,000,000
additions to long-term debt	1,242,000,000	0			1,599,000,000	1,344,000,000			1,428,000,000				0	2,249,000,000			1,988,000,000	0			0				-1,000,000	0			0	0	2,948,000,000	2,124,000,000	962,000,000	0	1,750,000,000	891,000,000	0
reductions in long-term debt	-499,000,000	0	-1,408,000,000	-70,000,000	0	0	-1,331,000,000	-1,004,000,000	-1,000,000	0	0	-1,877,000,000
treasury stock purchases	-700,000,000	-1,351,000,000	-2,510,000,000	-1,939,000,000	-1,516,000,000	-987,000,000	-1,003,000,000	-1,500,000,000	0	-1,351,000,000	-2,002,000,000	-4,000,000,000	-1,250,000,000	-1,249,000,000	-4,754,000,000	-2,750,000,000	-3,000,000,000	-3,001,000,000	-3,008,000,000	-2,000,000,000	0	-901,000,000	-3,504,000,000	-3,000,000,000	-1,750,000,000	-1,250,000,000	-751,000,000	-1,252,000,000	-1,370,000,000	-1,381,000,000	-1,751,000,000	-2,502,000,000	-700,000,000	-2,001,000,000	-1,501,000,000	-1,002,000,000	-500,000,000
impact of stock options and other	106,000,000	616,000,000	240,000,000	745,000,000	940,000,000	568,000,000	85,000,000	312,000,000	408,000,000	424,000,000	249,000,000	188,000,000	205,000,000	585,000,000	567,000,000	648,000,000	174,000,000	369,000,000	208,000,000	893,000,000	217,000,000	701,000,000	185,000,000	875,000,000	734,000,000	1,104,000,000	1,061,000,000	425,000,000	19,000,000	460,000,000	118,000,000	580,000,000	75,000,000	1,324,000,000	137,000,000	937,000,000	648,000,000
total financing activities	-3,616,000,000	-4,215,000,000	-5,571,000,000	-634,000,000	-2,499,000,000	-4,269,000,000	-6,049,000,000	-2,038,000,000	-3,893,000,000	-1,753,000,000	-2,993,000,000	-3,507,000,000	-4,158,000,000	-4,432,000,000	-2,858,000,000	-3,428,000,000	-3,085,000,000	-5,275,000,000	-6,441,000,000	-6,730,000,000	-3,399,000,000	5,945,000,000	-6,795,000,000	-4,118,000,000	-3,304,000,000	-5,066,000,000	1,032,000,000	-2,656,000,000	-6,861,000,000	-5,638,000,000	-152,000,000	-1,724,000,000	-2,229,000,000	-1,600,000,000	-4,232,000,000	-507,000,000	-3,655,000,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	134,000,000	122,000,000	-260,000,000	116,000,000	-83,000,000	-119,000,000	107,000,000	-156,000,000	0	12,000,000	53,000,000	-235,000,000	-185,000,000	-56,000,000	-129,000,000	-127,000,000	36,000,000	-81,000,000	115,000,000	31,000,000	40,000,000	-170,000,000	56,000,000	-65,000,000	7,000,000	18,000,000	-43,000,000	-70,000,000
change in cash, cash equivalents and restricted cash	440,000,000	-1,113,000,000	-1,927,000,000	2,675,000,000	2,653,000,000	-1,062,000,000	-1,843,000,000	1,487,000,000	650,000,000	742,000,000	144,000,000	-504,000,000	-1,312,000,000	-3,018,000,000	1,174,000,000	82,000,000	281,000,000	-1,934,000,000	-1,451,000,000	-2,789,000,000	788,000,000	9,114,000,000	-3,025,000,000	5,065,000,000	1,501,000,000	-958,000,000	1,151,000,000	-24,000,000
cash, cash equivalents and restricted cash, end of year
supplemental disclosure
cash payments for interest
cash payments for income taxes
cash, cash equivalents and restricted cash, beginning of period		0	0	9,482,000,000		0	0	8,246,000,000		0	0	7,214,000,000		0	0	10,288,000,000		0	0	16,181,000,000		0	0	4,239,000,000		0	0	2,569,000,000
change in accounts payable and accrued and other liabilities		-509,000,000	-509,000,000	-648,000,000
change in other operating assets and liabilities		-377,000,000	-190,000,000	-558,000,000
cash, cash equivalents and restricted cash, end of period		-1,114,000,000	-1,926,000,000	12,156,000,000		-1,062,000,000	-1,843,000,000	9,733,000,000		742,000,000	144,000,000	6,710,000,000		-3,018,000,000	1,174,000,000	10,370,000,000		-1,934,000,000	-1,451,000,000	13,392,000,000		9,114,000,000	-3,025,000,000	9,304,000,000		-958,000,000	1,151,000,000	2,545,000,000
gain on sale of assets						-48,000,000	0	-3,000,000		-1,000,000	-2,000,000	-1,000,000		-2,000,000	-9,000,000	-73,000,000			-2,000,000	-12,000,000		24,000,000	-11,000,000	-2,000,000	-308,000,000	0	-9,000,000	-361,000,000	11,000,000	-29,000,000	-77,000,000	-81,000,000
changes in:
accounts receivable						147,000,000	-9,000,000	-830,000,000		353,000,000	86,000,000	-740,000,000		-272,000,000	368,000,000	-1,012,000,000		-142,000,000	363,000,000	-825,000,000		392,000,000	4,000,000	-261,000,000		-151,000,000	77,000,000	-475,000,000		97,000,000	-243,000,000	-304,000,000		436,000,000	-171,000,000	-424,000,000
inventories						-15,000,000	110,000,000	-142,000,000		152,000,000	238,000,000	-893,000,000		-412,000,000	-431,000,000	-409,000,000		-182,000,000	-80,000,000	-137,000,000		0	16,000,000	-549,000,000		-70,000,000	-37,000,000	-494,000,000		0	-100,000,000	-357,000,000		102,000,000	40,000,000	-287,000,000
accounts payable and accrued and other liabilities						-246,000,000	-555,000,000	857,000,000
other operating assets and liabilities						-492,000,000	-33,000,000	-671,000,000		-304,000,000	-81,000,000	-454,000,000		-47,000,000	94,000,000	-178,000,000		-78,000,000	16,000,000	-30,000,000		-3,000,000	-20,000,000	-35,000,000		-167,000,000	-286,000,000	-84,000,000		-193,000,000	2,554,000,000	-30,000,000		67,000,000	17,000,000	135,000,000
net additions to other short-term debt								2,172,000,000				1,727,000,000
loss on early extinguishment of debt																	0	0															0	0
accounts payable, accrued and other liabilities										-786,000,000	-1,318,000,000	1,495,000,000		-84,000,000	170,000,000	1,261,000,000		737,000,000	-130,000,000	442,000,000		-220,000,000	-193,000,000	1,151,000,000		300,000,000	208,000,000	933,000,000		-105,000,000	622,000,000	235,000,000		-817,000,000	-594,000,000	298,000,000
net reductions to other short-term debt										1,372,000,000
proceeds from sales and maturities of short-term investments												55,000,000													1,093,000,000	1,418,000,000	468,000,000	649,000,000	1,138,000,000	1,147,000,000	1,255,000,000	388,000,000	654,000,000
change in accounts payable, accrued and other liabilities
purchases of investment securities
proceeds from sales and maturities of investment securities																					0	0	0	6,151,000,000
change in other investments													-1,000,000	1,000,000							-3,000,000	-3,000,000	0	1,000,000	-3,000,000	-1,000,000	-10,000,000	-48,000,000	-17,000,000	-6,000,000	18,000,000	32,000,000	-52,000,000	18,000,000	4,000,000	4,000,000
additions/(reductions) in other short-term debt
reductions of long-term debt																									33,000,000	-24,000,000			-1,471,000,000	-121,000,000	-1,130,000,000	-151,000,000	89,000,000	9,000,000	-4,028,000,000	-1,001,000,000	-3,000,000
reductions in other short-term debt
reductions to long-term debt														-1,103,000,000	-1,647,000,000	-26,000,000		-669,000,000	-4,195,000,000	-25,000,000		12,000,000
increases in short-term debt with original maturities of more than three months
increases/(reductions) in other short-term debt															-1,636,000,000	512,000,000
increases in short-term debt maturing in more than three months																1,792,000,000
reductions in short-term debt maturing in more than three months																-1,422,000,000
goodwill and indefinite-lived intangible impairment charges
increases/(reductions) in short-term debt																	48,000,000				-675,000,000
purchases of investments securities
reductions in short-term debt																			150,000,000	-3,568,000,000
purchases of short-term investments																									1,000,000	-1,000,000	0	-158,000,000	-139,000,000	-172,000,000	-1,656,000,000	-1,942,000,000	-1,474,000,000	-1,630,000,000	-1,108,000,000	-631,000,000	-443,000,000
cash payment for income taxes
assets acquired through non-cash finance leases are immaterial for all periods.
(reductions)/increases in short-term debt
change in short-term debt																								-61,000,000	-383,000,000	-3,038,000,000	1,182,000,000	24,000,000	-2,178,000,000	-2,783,000,000	1,476,000,000	48,000,000	-829,000,000	841,000,000	1,196,000,000	1,519,000,000	-1,953,000,000
cash transferred at closing related to the beauty brands divestiture																																	0	0
divestiture of beauty business in exchange for shares of p&g stock and assumption of debt
assets acquired through non-cash capital leases are immaterial for all periods.
cash and cash equivalents, beginning of year
goodwill and intangible asset impairment charges																																					0
pre-divestiture addition of restricted cash related to the beauty brands divestiture																																	0	0
release of restricted cash upon closing of the beauty brands divestiture																																	0	0
cash transferred in batteries divestiture																																					0
treasury stock from cash infused in batteries divestiture
effect of exchange rate changes on cash and cash equivalents																													-192,000,000	82,000,000	47,000,000	82,000,000	159,000,000	128,000,000	-273,000,000	-43,000,000	-85,000,000
change in cash and cash equivalents																													-2,757,000,000	-2,106,000,000	2,408,000,000	-545,000,000	-248,000,000	-234,000,000	-1,405,000,000	354,000,000	-793,000,000
cash and cash equivalents, end of year
divestiture of batteries business in exchange for shares of p&g stock
cash and cash equivalents, beginning of period																														0	0	5,569,000,000		0	0	7,102,000,000
cash and cash equivalents, end of period																														-2,106,000,000	2,408,000,000	5,024,000,000		-234,000,000	-1,405,000,000	7,456,000,000
cash transferred related to the beauty brands divestiture
restricted cash related to the beauty brands business
venezuela deconsolidation charge
cash related to deconsolidated venezuela operations
shares exchanged in batteries divestiture
gain on sale of businesses																																			-5,268,000,000	-75,000,000
proceeds from sales of short-term investments																																			111,000,000	243,000,000	132,000,000
cash transferred to discontinued beauty brands business																																				-348,000,000
restricted cash related to beauty brands divestiture																																				-874,000,000	-1,000,000
cash payments for:
interest
income taxes
loss/(gain) on sale of businesses

We provide you with 20 years of cash flow statements for Procter & Gamble stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Procter & Gamble stock. Explore the full financial landscape of Procter & Gamble stock with our expertly curated income statements.

The information provided in this report about Procter & Gamble stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.